Details of the Drug

General Information of Drug (ID: DMZ0K56)

Drug Name

DeNVax

Indication

Disease Entry	ICD 11	Status	REF
Dengue fever	1D2Z	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01511250) Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years. U.S. National Institutes of Health.